✦ LIBER ✦

Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus

✍ Scribed by Ippei Kanazawa; Shozo Yano; Yoshitomo Notsu; Toru Yamaguchi; Toru Nabika; Toshitsugu Sugimoto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An audit of glycaemic control and cardio

✍ P. Downey; L. O’Shea; D. Dillon; M. Corbett; S. Sreenan 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 726 KB

Sex- and BMI-related differences in risk

✍ S. Bo; L. Gentile; P. Cavallo-Perin; P. Vineis; V. Ghia 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 57 KB

Lipoprotein(a) as a coronary risk factor

📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 108 KB

Asymmetric dimethylarginine as an indepe

✍ R. H. Böger; H. G. Endres; E. Schwedhelm; H. Darius; D. Atzler; N. Lüneburg; B. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB

Efficacy and safety of dalcetrapib in ty

✍ A. F. H. Stalenhoef; M. H. Davidson; J. G. Robinson; T. Burgess; R. Duttlinger-M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

Lipoprotein(a) and homocysteine as genet

✍ Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Elisabetta Baffero; Adri 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 198 KB